| Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis (NCT07578116) | SWOG Cancer Research Network | 2027-03-09 |
| Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation (NCT07615049) | SWOG Cancer Research Network | 2026-12-02 |
| Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment (NCT07636564) | SWOG Cancer Research Network | 2026-10-14 |
| Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment (NCT07638722) | SWOG Cancer Research Network | 2026-10-03 |
| Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams (NCT07278739) | SWOG Cancer Research Network | 2026-09-03 |
| Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial (NCT07220187) | SWOG Cancer Research Network | 2026-08-31 |
| Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts (NCT07498205) | SWOG Cancer Research Network | 2026-08-08 |
| Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial) (NCT07393555) | SWOG Cancer Research Network | 2026-08-07 |
| Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer (NCT07383441) | SWOG Cancer Research Network | 2026-06-05 |
| Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations (NCT06998940) | SWOG Cancer Research Network | 2026-05-13 |
| Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer (NCT07062354) | SWOG Cancer Research Network | 2026-03-25 |
| Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study (NCT06769126) | SWOG Cancer Research Network | 2025-11-06 |
| Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors (NCT07018869) | SWOG Cancer Research Network | 2025-10-15 |
| Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) (NCT06616584) | SWOG Cancer Research Network | 2025-05-22 |
| Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula (NCT06807437) | SWOG Cancer Research Network | 2025-05-09 |
| Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body (NCT06470243) | SWOG Cancer Research Network | 2024-11-27 |
| Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial) (NCT06116682) | SWOG Cancer Research Network | 2024-11-19 |
| Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial) (NCT06031688) | SWOG Cancer Research Network | 2024-08-08 |
| Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis (NCT06022939) | SWOG Cancer Research Network | 2024-07-01 |
| Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation (NCT05806515) | SWOG Cancer Research Network | 2024-03-01 |
| Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment (NCT05561387) | SWOG Cancer Research Network | 2023-10-12 |
| Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer (NCT05929768) | SWOG Cancer Research Network | 2023-09-15 |
| Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05633615) | SWOG Cancer Research Network | 2023-06-12 |
| Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy (NCT05642611) | SWOG Cancer Research Network | 2023-06-06 |
| Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial) (NCT05642572) | SWOG Cancer Research Network | 2023-05-05 |
| Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study (NCT05568472) | SWOG Cancer Research Network | 2023-03-29 |
| Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study (NCT05633602) | SWOG Cancer Research Network | 2023-03-14 |
| Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment (NCT05455606) | SWOG Cancer Research Network | 2022-10-14 |
| Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL) (NCT04871529) | SWOG Cancer Research Network | 2022-08-10 |
| Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer (NCT05364645) | SWOG Cancer Research Network | 2022-07-25 |
| Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors (NCT05040360) | SWOG Cancer Research Network | 2022-05-05 |
| Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT05096663) | SWOG Cancer Research Network | 2022-03-15 |
| Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses (NCT04960787) | SWOG Cancer Research Network | 2021-10-12 |
| Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors (NCT04871542) | SWOG Cancer Research Network | 2021-09-13 |
| Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases (NCT04647916) | SWOG Cancer Research Network | 2021-06-08 |
| Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT04625647) | SWOG Cancer Research Network | 2021-04-16 |
| Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial (NCT04510597) | SWOG Cancer Research Network | 2021-03-08 |
| Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) (NCT04315324) | SWOG Cancer Research Network | 2021-02-08 |
| A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases (NCT04511013) | SWOG Cancer Research Network | 2021-01-06 |
| Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) (NCT04496739) | SWOG Cancer Research Network | 2020-10-23 |
| Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT04267913) | SWOG Cancer Research Network | 2020-09-05 |
| A Study of miRNA 371 in Patients With Germ Cell Tumors (NCT04435756) | SWOG Cancer Research Network | 2020-07-28 |
| Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers (NCT04205968) | SWOG Cancer Research Network | 2020-06-01 |
| S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer (NCT04155034) | SWOG Cancer Research Network | 2020-05-04 |
| Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial) (NCT04268550) | SWOG Cancer Research Network | 2020-04-08 |
| Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial) (NCT04173507) | SWOG Cancer Research Network | 2020-02-14 |
| Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors (NCT04205955) | SWOG Cancer Research Network | 2020-02-10 |
| S1916 Digital Medicine Program for Pain Control in Cancer Patients (NCT04194528) | SWOG Cancer Research Network | 2020-01-22 |
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors (NCT03887702) | SWOG Cancer Research Network | 2020-01-17 |
| S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (NCT04071457) | SWOG Cancer Research Network | 2019-08-13 |
| Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial) (NCT03971474) | SWOG Cancer Research Network | 2019-05-28 |
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT03845296) | SWOG Cancer Research Network | 2019-04-16 |
| Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery (NCT03694002) | SWOG Cancer Research Network | 2019-03-20 |
| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery (NCT03757949) | SWOG Cancer Research Network | 2019-03-05 |
| Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers (NCT03768414) | SWOG Cancer Research Network | 2019-02-07 |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer (NCT03678025) | SWOG Cancer Research Network | 2018-09-24 |
| S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer (NCT03723928) | SWOG Cancer Research Network | 2018-09-17 |
| S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis (NCT03499808) | SWOG Cancer Research Network | 2018-06-06 |
| Lung-MAP S1400K: c-MET Positive (NCT03574753) | SWOG Cancer Research Network | 2018-03-16 |
| Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer (NCT03373760) | SWOG Cancer Research Network | 2017-11-30 |
| S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882) | SWOG Cancer Research Network | 2017-11-27 |
| S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity (NCT03418961) | SWOG Cancer Research Network | 2017-11-01 |